The presented figures refer to specimens received during the designated month.
| Nasal swab specimens | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organism | Drugs* | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| Staphylococcus aureus | No. | 2 | 2 | 5 | 0 | 6 | 2 | 3 | 1 | 3 | 1 | 5 | 1 |
| Penicillin | 0% | 100% | 100% | - | 100% | 100% | 67% | 100% | 100% | 100% | 80% | 100% | |
| Oxacillin [MRSA] |
0% | 0% | 20% | - | 17% | 0% | 33% | 0 | 67% | 100% | 20% | 100% | |
| Clindamycin | 0% | 100% | 20% | - | 67% | 0% | 67% | 100% | 100% | 0% | 20% | 100% | |
| Erythromycin | 0% | 100% | 40% | - | 67% | 50% | 67% | 100% | 100% | 0% | 20% | 100% | |
| Gentamicin | 0% | 0% | 0% | - | 17% | 0% | 0% | 0% | 33% | 0% | 0% | 100% | |
| Throat swab specimens | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organism | Drugs* | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| Beta-haemolytic streptococcus of Lancefield Group A, C & G | No. | 6 | 10 | 8 | 11 | 10 | 8 | 11 | 2 | 7 | 8 | 14 | 7 |
| Penicillin | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | |
| Erythromycin | 67% | 50% | 50% | 64% | 60% | 25% | 27% | 0% | 71% | 63% | 50% | 43% | |
| Sputum specimens | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organism | Drugs* | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| Streptococcus pneumoniae | No. | 13 | 12 | 4 | 23 | 4 | 6 | 12 | 11 | 12 | 7 | 11 | 13 |
| Penicillin | 15% | 17% | 0% | 17% | 25% | 0% | 8% | 36% | 8% | 29% | 27% | 23% | |
| Erythromycin | 69% | 83% | 75% | 83% | 100% | 83% | 100% | 82% | 67% | 71% | 82% | 92% | |
| Levofloxacin | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | |
| Haemophilus influenzae | No. | 93 | 111 | 138 | 128 | 173 | 152 | 125 | 118 | 89 | 93 | 86 | 98 |
| Ampicillin | 48% | 44% | 52% | 44% | 46% | 47% | 52% | 47% | 42% | 40% | 40% | 50% | |
| Amoxicillin + clavulanic acid | 8% | 18% | 16% | 9% | 14% | 16% | 23% | 11% | 11% | 9% | 7% | 16% | |
| Moraxella catarrhalis | No. | 70 | 71 | 78 | 61 | 54 | 44 | 30 | 28 | 15 | 41 | 149 | 200 |
| BL+ | 100% | 99% | 100% | 98% | 100% | 98% | 100% | 96% | 93% | 100% | 97% | 99% | |
| Urine specimens | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organism | Drugs* | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| Escherichia coli | No. | 433 | 458 | 574 | 434 | 489 | 600 | 531 | 648 | 538 | 591 | 534 | 456 |
| Ampicillin | 69% | 67% | 72% | 64% | 69% | 65% | 68% | 69% | 64% | 66% | 70% | 71% | |
| Amoxicillin + clavulanic acid | 7% | 6% | 3% | 5% | 4% | 6% | 5% | 7% | 6% | 7% | 6% | 5% | |
| Nalidixic acid | 73% | 73% | 77% | 69% | 74% | 69% | 72% | 71% | 73% | 74% | 71% | 74% | |
| Nitrofurantoin | 0% | 0% | 1% | 0% | 1% | 1% | 0% | 0% | 1% | 1% | 1% | 1% | |
| Co-trimoxazole | 35% | 37% | 36% | 29% | 34% | 31% | 35% | 38% | 34% | 33% | 35% | 37% | |
| Levofloxacin | 31% | 33% | 35% | 26% | 30% | 29% | 31% | 32% | 31% | 33% | 31% | 29% | |
| ESBL+ | 20% | 20% | 17% | 15% | 17% | 15% | 18% | 21% | 16% | 19% | 17% | 19% | |
| Klebsiella pneumoniae^ | No. | 84 | 78 | 107 | 65 | 78 | 96 | 98 | 105 | 102 | 100 | 86 | 65 |
| Amoxicillin + clavulanic acid | 6% | 3% | 4% | 8% | 12% | 10% | 13% | 9% | 10% | 10% | 13% | 5% | |
| Nalidixic acid | 26% | 24% | 16% | 18% | 23% | 22% | 29% | 23% | 27% | 26% | 29% | 23% | |
| Nitrofurantoin | 11% | 15% | 21% | 17% | 17% | 26% | 15% | 12% | 14% | 18% | 21% | 17% | |
| Co-trimoxazole | 23% | 13% | 10% | 15% | 13% | 16% | 20% | 15% | 25% | 21% | 26% | 20% | |
| Levofloxacin | 6% | 5% | 7% | 8% | 8% | 9% | 9% | 8% | 10% | 8% | 13% | 12% | |
| ESBL+ | 17% | 10% | 8% | 12% | 6% | 11% | 9% | 10% | 9% | 12% | 10% | 11% | |
| Proteus mirabilis^^ | No. | 52 | 57 | 51 | 40 | 62 | 64 | 63 | 64 | 80 | 63 | 71 | 48 |
| Ampicillin | 37% | 51% | 39% | 58% | 39% | 38% | 35% | 47% | 50% | 43% | 39% | 48% | |
| Amoxicillin + clavulanic acid | 2% | 9% | 6% | 10% | 0% | 6% | 2% | 9% | 8% | 10% | 6% | 17% | |
| Nalidixic acid | 44% | 40% | 27% | 63% | 39% | 30% | 24% | 42% | 46% | 30% | 44% | 44% | |
| Co-trimoxazole | 37% | 44% | 35% | 53% | 37% | 39% | 27% | 45% | 48% | 33% | 32% | 46% | |
| Levofloxacin | 15% | 25% | 18% | 35% | 23% | 11% | 17% | 27% | 29% | 19% | 24% | 25% | |
| Enteric specimens | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organism | Drugs* | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| Campylobacter spp. | No. | 4 | 1 | 0 | 0 | 2 | 0 | 0 | 4 | 1 | 0 | 0 | 2 |
| Erythromycin | 75% | 0% | - | - | 0% | - | - | 50% | 100% | - | - | 0% | |
| Salmonella spp. | No. | 3 | 2 | 4 | 4 | 8 | 9 | 7 | 7 | 14 | 15 | 9 | 3 |
| Ampicillin | 67% | 0% | 25% | 25% | 50% | 56% | 71% | 71% | 14% | 27% | 56% | 0% | |
| Co-trimoxazole | 33% | 0% | 0% | 0% | 13% | 33% | 14% | 29% | 14% | 13% | 22% | 0% | |
| Ciprofloxacin | 0% | 0% | 0% | 0% | 0% | 11% | 0% | 0% | 0% | 7% | 11% | 0% | |
| Shigella spp. | No. | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Ampicillin | - | - | - | - | 100% | - | - | - | - | - | - | 100% | |
| Ciprofloxacin | - | - | - | - | 100% | - | - | - | - | - | - | 100% | |
| Vibrio spp. | No. | 3 | 1 | 0 | 1 | 1 | 4 | 11 | 9 | 6 | 6 | 3 | 2 |
| Tetracycline | 0% | 0% | - | 0% | 0% | 0% | 9% | 0% | 0% | 0% | 0% | 0% | |
| Soft tissue specimens | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organism | Drugs* | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| Staphylococcus aureus | No. | 60 | 81 | 78 | 63 | 80 | 84 | 90 | 104 | 88 | 69 | 89 | 89 |
| Oxacillin [MRSA] |
28% | 28% | 21% | 38% | 18% | 19% | 28% | 22% | 24% | 32% | 24% | 29% | |
*Abbreviations:
MRSA = methicillin resistant Staphylococcus aureus
BL+ = beta-lactamse positive
ESBL+ = extended-spectrum beta-lactamase positive
^ Klebsiella pneumoniae is 100% resistant to ampicillin.
^^Proteus mirabilis is 100% resistant to nitrofurantoin.